Skip to content. | Skip to navigation

Sections
IMPaCT Trial

Individualised Molecular Pancreatic Cancer Therapy (IMPaCT) is a new clinical trial looking at individualising the treatment of patients with metastatic pancreatic cancer.

Make a Donation

Help the APGI and ensure our work continues. Make a donation today.

Get Email Updates
Familial Cancer Cohort

If you would like to be involved in the project please click here to find out more.

 

Symptoms

Pancreatic cancer is often difficult to detect due to its anatomical location, in that it is hidden behind other major organs such as the stomach, small intestine, liver, gallbladder and spleen.

Early stages of pancreatic cancer rarely cause symptoms. Symptoms are not often noticed until the cancer is big enough to touch and affect organs nearby.

Early signs of pancreatic cancer include:

  • Pain in the upper abdomen
  • Loss of appetite
  • Nausea and vomiting
  • Weight loss
  • Changed bowel motions - either diarrhoea or severe constipation
  • Yellowish skin and eyes, and dark urine - these signs are caused by a condition called jaundice, which occurs if the tumour blocks the bile duct into the digestive system.


Less common signs include:

  • Severe back pain
  • Onset of diabetes mellitus - 10-20% of people with pancreatic cancer develop diabetes mellitus as the cancer stops the pancreas from producing insulin properly.


All these symptoms are common to many conditions and may not mean you have pancreatic cancer. However, if you have any of these symptoms and are concerned, please consult with your doctor.

Watch the Cancer Council of NSW's video on recognising symptoms here.